By integrating transcriptomic profiling, computational deconvolution algorithms, and clinical validation, our analysis identified four hub genes—IL10, MRC1, CD163, and FCGR2B—as central mediators of AML prognosis. The gene discussed is MRC1; the disease is acute myeloid leukemia.